# The Better Systems Project Pre-Memo Brief #003: Healthcare Affordability

Version: v0.1 public reviewer brief
Date: 2026-07-03
Status: Public pre-memo review draft, not a final policy memo or medical, legal, benefits, debt, or insurance advice

Related public paper: https://sethusehitch.github.io/patch-notes-society/issues/003-healthcare.html
Evidence anchors: https://sethusehitch.github.io/patch-notes-society/evidence.html#003-healthcare

## Purpose

This brief prepares Patch Notes for Society #003 for expert review before it becomes a formal policy memo. The goal is to separate healthcare affordability into tractable mechanisms, identify where public arguments overstate easy fixes, and ask reviewers which tradeoffs need to be named before any submission-grade proposal exists.

This is not medical advice, clinical guidance, insurance advice, benefits advice, legal advice, debt advice, or a recommendation for any individual coverage, treatment, billing, or claims decision.

## Core Question

Why does U.S. healthcare cost so much, where does the money go, and what migration plan could make care more affordable without breaking access, quality, innovation, clinician capacity, rural systems, safety-net systems, or patient trust?

## What This Is Not Claiming

- There is one villain or one fix.
- Insurance design is the whole problem.
- Government, markets, single payer, public options, competition, or deregulation can be evaluated without tradeoffs.
- Lower spending is automatically better if access, staffing, quality, or useful care collapses.
- Every high price is waste.
- Every administrative cost is unnecessary.
- Peer-country models can be copied without institutional migration costs.
- Medical debt protection solves the underlying price and financing system by itself.

## Working Frame

Healthcare affordability is not one problem. A credible migration plan must separate at least six levers:

1. Prices: what hospitals, physicians, drug companies, and other providers are paid.
2. Utilization: how much care people use, including useful care, low-value care, delayed care, and avoided care.
3. Insurance design: premiums, deductibles, networks, claims, prior authorization, and risk pooling.
4. Market structure: consolidation, bargaining power, antitrust, and local provider scarcity.
5. Administration: billing, coding, claims, compliance, quality reporting, fraud control, and patient navigation.
6. Capacity and quality: clinician workforce, rural access, safety-net viability, innovation, and outcomes.

The policy question is not "government versus market." It is which prices, incentives, administrative rules, and delivery models produce affordable care without destroying access or useful capacity.

## Non-Negotiable Distinctions

| Distinction | Why it matters | Review rule |
| --- | --- | --- |
| Total spending vs household affordability | National spending can rise while different households feel very different pain | Separate public budget, employer, insurer, and household effects. |
| Prices vs utilization | High spending can come from high prices, high use, low-value care, or delayed care becoming expensive care | Do not imply one lever explains the whole system. |
| Premiums vs deductibles vs out-of-pocket costs | People experience affordability through different channels | Track who pays, when, and under what plan design. |
| Provider market power vs provider fragility | Some systems have pricing power; others are financially fragile | Avoid one-size-fits-all price policy. |
| Administrative waste vs necessary administration | Billing friction and prior authorization can harm patients and clinicians, but some controls manage fraud, quality, risk, and safety | Name what should be simplified and what must still be governed. |
| Drug list prices vs net prices vs PBM flows | Public debate often collapses the supply chain | Ask pharmacy and payer reviewers where money actually moves. |
| Medical debt relief vs cost reduction | Debt relief can protect patients after harm but may not lower underlying costs | Treat it as patient protection, not the whole affordability strategy. |

## Guardrails For The Future Memo

### Patient Affordability

The memo should distinguish premiums, deductibles, coinsurance, copays, denied claims, out-of-network bills, drug costs, medical debt, and delayed or forgone care. A family can be insured and still unable to afford care.

### Prices And Market Power

The memo can say that prices matter, but should not imply every high payment is pure waste. Reviewer work should separate hospital market power, safety-net fragility, rural access, physician employment, site-of-care payment, payer bargaining, and service-line economics.

### Administration

Administrative burden should be treated as both a cost problem and a workflow problem. The future memo should distinguish billing/coding complexity, prior authorization, claims denial, quality reporting, fraud control, network design, patient navigation, and compliance.

### Reform Tradeoffs

Every reform should name what it could break: access, quality, safety-net capacity, rural viability, clinician time, innovation, employer coverage, public budgets, or patient choice. The memo should not present any payment model as magic.

## Review Questions

1. Where does the public paper confuse spending, prices, premiums, deductibles, out-of-pocket costs, and medical debt?
2. Which cost driver is overstated or understated?
3. Which reform would lower one cost while increasing another?
4. Where would price regulation fail because capacity is fragile?
5. Where would competition fail because the local market cannot support it?
6. Which administrative burden is real waste, and which is a crude workaround for fraud, quality, safety, or risk?
7. Which drug/PBM claim needs a sharper source before inclusion?
8. What should a practical migration plan sequence first?
9. Which metric would be easiest to game?
10. What would make the memo feel naive to patients, clinicians, employers, payers, hospitals, or state budget officials?

## Reviewers Needed

- Health economists and health-policy researchers.
- Clinicians, nurses, practice administrators, and hospital operators.
- Patient advocates, medical-debt advocates, and benefits navigators.
- Employer-benefits experts, payers, actuaries, and plan administrators.
- Pharmacy, drug-pricing, and PBM reviewers.
- Rural health, safety-net, Medicaid, Medicare, and state-budget reviewers.

## What Would Make This Memo Ready For v0.1

- The core cost map separates prices, utilization, insurance design, market structure, administration, and capacity.
- Patient affordability is described separately from national spending.
- Provider-market-power claims distinguish consolidated systems from fragile providers.
- Drug pricing and PBM claims are source-grounded and not overgeneralized.
- Administrative simplification names which controls remain necessary.
- Reform tradeoffs and stop conditions are explicit.
- Metrics include household affordability, access, quality, clinician capacity, public budgets, employer costs, and unintended consequences.